SCHEMBL8075666

SCHEMBL8075666

CCCN1C(=O)C(NC(=O)CCc2ccc(Cl)cc2Cl)C(=O)N(CCC)c2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.55
ALDH1A1 P00352 5/20 0.47
CCKBR P32239 6/20 0.44
P2RX7 Q99572 3/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PDPK1 O15530 1/20 0.40
HPGD P15428 1/20 0.40
PPARG P37231 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7048902 0.93 KCNH2 (0.52) KCNH2ALDH1A1CCKBR
SCHEMBL8075702 0.89 ALDH1A1 (0.49) KCNH2ALDH1A1CCKBRP2RX7MEN1
SCHEMBL7861646 0.83 KCNH2 (0.50) KCNH2ALDH1A1CCKBRP2RX7KDM4E
SCHEMBL7817780 0.83 KCNH2 (0.55) KCNH2ALDH1A1CCKBRP2RX7KDM4E
SCHEMBL8075815 0.82 KCNH2 (0.59) KCNH2ALDH1A1CCKBRP2RX7KMT2A
SCHEMBL8075665 0.82 KCNH2 (0.49) KCNH2ALDH1A1CCKBRP2RX7KDM4E
SCHEMBL7045631 0.81 KCNH2 (0.53) KCNH2CCKBRP2RX7PDPK1HPGD
SCHEMBL7816350 0.81 KCNH2 (0.53) KCNH2ALDH1A1CCKBRP2RX7KDM4E
SCHEMBL7046124 0.78 CCKBR (0.49) KCNH2CCKBRP2RX7PDPK1HPGD
SCHEMBL8075704 0.77 ALDH1A1 (0.52) KCNH2ALDH1A1CCKBRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832075-B1 N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 2000-10-11 EP claimed
EP-0832075-A4 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 1998-10-07 EP claimed
EP-0832075-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES Merck & Co., Inc. (US) 1998-04-01 EP claimed
US-5691331-A N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides MERCK & CO., INC. (US) 1997-11-25 US claimed
WO-1996040655-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO., INC. (US) 1996-12-19 WO claimed
EP-0832075-B1 N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 2000-10-11 EP disclosed
EP-0832075-A4 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 1998-10-07 EP disclosed
EP-0832075-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES Merck & Co., Inc. (US) 1998-04-01 EP disclosed
US-5691331-A N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides MERCK & CO., INC. (US) 1997-11-25 US disclosed
WO-1996040655-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO., INC. (US) 1996-12-19 WO disclosed